Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Acq. announced
Consulting agrmnt
CC transcript
Filed Chapter 11
Appointed director
Asset disposition
Credit agrmnt [a]

IMPLANT SCIENCES CORP (IMSC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2016 8-K Form 8-K - Current report
08/01/2016 8-K Form 8-K - Current report
05/19/2016 8-K Form 8-K - Current report
02/19/2016 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2016 FINANCIAL RESULTS Quarterly revenue increase 380.7% to $10.3 million Six months revenue increase 515.6% to $24.7 million",
"Implant Sciences Corporation conference call transcript held on February 11, 2016"
11/18/2015 8-K Quarterly results, Conference call transcript
Docs: "IMSC_3PATENTS PR (EGS 5.8.15) (00359966).DOCX",
"Implant Sciences Corporation conference call transcript held on November 12, 2015"
10/02/2015 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2015 FINANCIAL RESULTS",
"Implant Sciences Corporation conference call transcript held on September 28, 2015"
05/20/2015 8-K Quarterly results, Conference call transcript
Docs: "Implant Sciences Corporation Condensed Consolidated Balance Sheets",
"Implant Sciences Corporation conference call transcript held on May 14, 2015 at 4:15 PM ET"
02/20/2015 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2015 FINANCIAL RESULTS Wilmington, MA…February 17, 2015…Implant Sciences Corporation , a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three and six months ended December 31, 2014. Revenues for the three months ended December 31, 2014 decreased 32.0%, to $2.1 million, from $3.2 million for the comparable prior year period. Our net loss for the three months ended December 31, 2014 was $6.2 million as compared with a net loss of $4.4 million for the comparable prior year period, an increase of $1.8 million. Revenues for the six months ended December 31, 2014 decreased 7.1%, to $4.0 million, from $4.3 million for the comparable prior year period. ...",
"Implant Sciences Corporation conference call transcript held on February 17, 2015 at 4:15 PM ET"
10/01/2014 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2014 FINANCIAL RESULTS",
"Transcript of Implant Sciences Corporation conference call held on September 29, 2014 at 4:15 PM ET"
05/12/2006 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy